US Patent Issued to Momenta Pharmaceuticals on May 13 for "Methods for the treatment of neurodegeneration" (New Jersey Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,256, issued on May 13, was assigned to Momenta Pharmaceuticals Inc. (Titusville, N.J.).

"Methods for the treatment of neurodegeneration" was invented by Thomas E. Prod'Homme (Titusville, N.J.), Leona E. Ling (Titusville, N.J.), Carlos J. Bosques (Titusville, N.J.), Anthony Manning (Titusville, N.J.) and Ganesh Kaundinya (Titusville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention encompasses the discovery that Fc-containing polypeptides that include branched glycans and that are sialylated on the branched glycan (e.g., on an Alpha 1,3 and/or Alpha 1,6 arm in the Fc region's N-linked glycosylation site), with, e.g., a NeuAc-Alpha 2,...